RecruitingNCT03409159

Austrian Left Atrial Appendage Closure Registry

Sponsor

Medical University of Graz

Enrollment

200 participants

Start Date

May 16, 2017

Study Type

OBSERVATIONAL

Conditions

Atrial Fibrillation Left Atrial Appendage Closure

Summary

Left atrial appendage (LAA) occlusion (LAAC) has been introduced to treat patients with indication of oral anticoagulation (OAC) for atrial fibrillation (AF) with contraindication to OAC. This registry aims to document all LAAC procedures in Austria.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry (a large data collection study) tracking outcomes for patients in Austria who have had a procedure to close off a small pouch in the heart called the left atrial appendage — a procedure done to reduce the risk of stroke in people with an irregular heart rhythm (atrial fibrillation). **You may be eligible if...** - You have had a left atrial appendage closure procedure performed in Austria - You are willing to provide informed consent for your data to be included **You may NOT be eligible if...** - You have not had this procedure performed in Austria - You decline to provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.